Collaxio (COLLAX) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
4 Nov, 2026Executive summary
Q3 2026 net result was SEK 0.6m, versus a SEK 1.5m loss in Q3 2025; NAV was SEK 101m and AUM SEK 109m at quarter-end.
Investment focus broadened to individual-company secondaries, alongside portfolio acquisitions and a new monitoring and administration service for private holdings.
No new portfolio acquisitions were completed in Q3; management aims to convert ongoing discussions into transactions in Q4.
Financial highlights
Q3 total result was SEK 556k versus a SEK 1,476k loss YoY; EPS was SEK 0.01 versus SEK -0.03.
Jan-Sep result was a SEK 1.384m loss versus a SEK 23.833m loss; EPS was SEK -0.02 versus SEK -0.65.
Q3 fair-value changes were positive SEK 2.666m; Jan-Sep changes were positive SEK 5.367m, including SEK 2.167m from portfolio holdings and SEK 3.203m from convertible debt.
Cash was SEK 25.690m and equity SEK 101.092m at Sep 30, 2026, versus SEK 36.389m and SEK 88.851m at Dec 31, 2025.
2025 comparisons partly reflect the prior listed-Asian-equities business and are not fully comparable with current operations.
Outlook and guidance
Q4 objective is to turn deal discussions into transactions; the widened mandate now includes single-asset secondary investments.
The new private-holdings monitoring and administration service secured its first customer agreement after quarter-end.
Latest events from Collaxio
- NAV increased to 100 MSEK as portfolio expanded to 21 holdings, with improved Q2 results.COLLAX
Q2 2026 - NAV at 89 MSEK, 19 holdings, 61% portfolio revenue growth, and improved cost efficiency.COLLAX
Q1 2026 - Strategic shift to unlisted assets and acquisitions drove transformation, but NAV per share fell.COLLAX
Q4 2025 - Strategisk omställning och portföljförvärv ledde till minskat substansvärde och negativt resultat.COLLAX
Q3 2025 - Strategic pivot to unlisted investments, with NAV per share dropping and major portfolio acquisition.COLLAX
Q2 2025 - NAV per share up 11% in Q3, with strong portfolio growth and improved profitability.COLLAX
Q3 2024 - Substansvärdet per stamaktie minskade 11% under H1 2024, men resultatet förbättrades.COLLAX
Q2 2024 - Substansvärdet minskade 6% och hela portföljen föreslås avyttras med extrautdelning.COLLAX
Q1 2025 - Stark vändning till positivt resultat och höjd utdelning trots lägre substansvärde.COLLAX
Q4 2024